Diagnostic accuracy of the novel and biosafe molecular assay Orange G3 TBC compared to GeneXpert for tuberculosis diagnosis in resource-limited settings
| dc.contributor.author | J C Garberi | |
| dc.contributor.author | Gabriel Estryk | |
| dc.contributor.author | Richard Chiara | |
| dc.contributor.author | Patricia Callisperis | |
| dc.contributor.author | Patricia Loza | |
| dc.contributor.author | Luis Scigliano | |
| dc.contributor.author | Sandra Andrea Casevecchie | |
| dc.contributor.author | Juan Ezequiel Garberi | |
| dc.contributor.author | Edgar Villarte | |
| dc.contributor.author | Mike Acevedo | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T19:47:27Z | |
| dc.date.available | 2026-03-22T19:47:27Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | The Orange G3 TBC platform offers comparable diagnostic accuracy to GeneXpert Ultra. The system is adaptable to resource-limited settings, making it a viable alternative for TB diagnosis in endemic regions. | |
| dc.identifier.doi | 10.1177/20499361251386681 | |
| dc.identifier.uri | https://doi.org/10.1177/20499361251386681 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/78136 | |
| dc.language.iso | en | |
| dc.publisher | SAGE Publishing | |
| dc.relation.ispartof | Therapeutic Advances in Infectious Disease | |
| dc.source | Universidad de Buenos Aires | |
| dc.subject | GeneXpert MTB/RIF | |
| dc.subject | Medicine | |
| dc.subject | Diagnostic accuracy | |
| dc.subject | Tuberculosis | |
| dc.subject | Tuberculosis diagnosis | |
| dc.subject | Orange (colour) | |
| dc.subject | Diagnostic test | |
| dc.title | Diagnostic accuracy of the novel and biosafe molecular assay Orange G3 TBC compared to GeneXpert for tuberculosis diagnosis in resource-limited settings | |
| dc.type | article |